Stem Cell Therapy in Autoimmune Diseases

Biomarkers, represented by genetically determined traits or biologic changes predictive of disease onset or outcome, are increasingly employed by academic and industrial investigators. They can identify unusually susceptible populations or individuals, facilitate prognosis, Currently, autoimmune conditions are treated with immune suppressive agents such as steroids, methothrexate, cyclosporine, gold, and more recently infliximab (Remicade). 
 

  • Hematopoietic Stem Cell Therapy for Autoimmune Diseases
  • Development of Hematopoietic Stem Cell Lines for Transplantation
  • Gene Therapy and Stem Cell Approaches for the Treatment of Autoimmune Diseases

Related Conference of Stem Cell Therapy in Autoimmune Diseases

April 04-05, 2024

38th International Conference on Immunology

Madrid, Spain
May 23-24, 2024

18th International Conference on European Immunology

Zurich, Switzerland

Stem Cell Therapy in Autoimmune Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in